PCI welcomes UK Government to its US Center of Excellence

Official Trade Mission aims to build further on strong investment and trade relations between US and Wales

International pharmaceutical outsourcing services provider PCI Pharma Services (PCI) welcomed an official visit by the UK Government to its US Headquarters in Philadelphia, Pennsylvania this week.

Led by Secretary of State for Wales and UK Board of Trade Advisor Alun Cairns, the engagement was part of a trade mission to attract US businesses to invest in Wales and build on a commercial relationship already worth more than $46 billion (£33.5 billion).

During the three-day visit to New York, New Jersey and Pennsylvania, Cairns met with representatives from innovative pharmaceutical and biotechnology sectors such as PCI as well as with companies from other sectors such as cyber security.

The Secretary of State said: “Wales and the US are close trading partners and I want to ensure that we continue to build on this important relationship by creating more investment and exporting opportunities for companies from both countries.”

“US firms invest more than £30 billion in the UK and our commercial relationship is stronger than ever. We want to see that partnership continue to grow and flourish, making Wales the place of choice for investors.”

PCI Pharma Services President and CEO Bill Mitchell, said: “The visit pays great testimony to our US operations, but also our ongoing commitment to our EU operations. Our Welsh sites play a very important part in delivering on our strategy to be the partner of choice for pharmaceutical and biotech companies to bring lifesaving medicines to patients around the world.”

Based in Pennsylvania, PCI has eight sites across North America and Europe, including four in Wales, UK. The organisation has a comprehensive corporate strategy for continued global expansion, focused on organic and acquisitive growth, in response to pharmaceutical trends and customer needs.

PCI was chosen as a host for the UK Government’s Trade Mission visit in recognition of its long-standing relationship with Wales. PCI recently announced its newly expanded European Clinical Services Center of Excellence at Bridgend.

Prior to this, PCI announced the expansion of its European Manufacturing Center of Excellence at Tredegar. Both capital site expansions were part of an ongoing investment programme to increase capacity and capability across PCI’s Welsh sites.

Featured Companies

PCI Pharma Services (more information, website)